Spanish Red Biotech Pipeline

Gilead Sciences

Sacituzumab govitecan-hziy + combinations 

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: 1L metastatic urothelial carcinoma
Phase: 2Phase II in Spain, 1Phase I in Spain